NCT01273844View on ClinicalTrials.gov

Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 1, 2011

Primary Completion Date

May 12, 2016

Study Completion Date

May 12, 2016

Conditions
Amyloidosis
Interventions
DRUG

Bortezomib

Bortezomib

Trial Locations (1)

215325

Soochow University, Suzhou

Sponsors
All Listed Sponsors
collaborator

Soochow University

OTHER

collaborator

Nanjing Medical University

OTHER

lead

Zhi-Hong Liu, M.D.

OTHER